Table 3—

Duration of estrogen use and the risk of type 2 diabetes in current users

Definition of diabetes Models (n=134)VariablesOR95% CICovariates remaining in the final model
Fasting glucose ≥7.0 mmol/l
(new diabetes=6)
 UnadjustedDuration*1.010.9–1.12
 AdjustedDuration1.010.9–1.12None
Fasting glucose ≥7.0 mmol/l or 2-h
glucose ≥11.1 mmol/l (new diabetes=16)
 UnadjustedDuration1.020.96–1.10
 AdjustedDuration1.101.01–1.18BMI, hysterectomy status (yes or no)
2-h glucose ≥11.1 mmol/l
 (new diabetes=14)
 UnadjustedDuration1.020.95–1.10
 AdjustedDuration1.101.01–1.19BMI, hysterectomy status (yes or not)
  • *

    * Duration of estrogen use (years).

  • Covariates remaining in the final selected logistic model were selected as described in Table 2 and in research design and methods.